A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy.

Lauren A Zatarain, Derek K Smith, Jie Deng, Jill Gilbert, Mary S Dietrich, Kenneth J Niermann, Sheila H Ridner, Barbara A Murphy

Journal: Integrative cancer therapies 2019;17(3):960-967

PMID: 29952235

Abstract

OBJECTIVE

This study was designed to assess the feasibility of using the Jaw Dynasplint System as an adjunct to conventional stretching exercises as a preventative measure against trismus in patients undergoing radiotherapy.

METHODS

Study participants (n = 40) were randomized using a permuted block design to conventional stretching or stretching plus use of the Jaw Dynasplint 3 times per day for 30 minutes. Patients were instructed to record maximum interincisal opening each day as well as logging use of the Jaw Dynasplint.

RESULTS

At 6 months after initiation of the preventative regimen, 50% of patients in the Dynasplint arm and 75% in the conventional stretching arm remained on their assigned therapy. Trismus was diagnosed in 2 patients in the control arm and in 4 patients in the Dynasplint arm. Only 25% (95% confidence interval = 11.1, 46.9) of patients in the Dynasplint arm used the device as prescribed.

CONCLUSIONS

The addition of the Jaw Dynasplint decreased compliance compared with conventional stretching. It is unlikely that the prescribed regimen will prove efficacious as a preventative measure due to low compliance.

Address: 1 Our Lady of the Lake Physician Group, Baton Rouge, LA, USA.; 2 Vanderbilt University Medical Center, Nashville, TN, USA.; 3 University of Pennsylvania, Philadelphia, PA, USA.; 4 Vanderbilt University, Nashville, TN, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.